标题
Cystic Fibrosis
作者
关键词
-
出版物
NEW ENGLAND JOURNAL OF MEDICINE
Volume 389, Issue 18, Pages 1693-1707
出版商
Massachusetts Medical Society
发表日期
2023-11-02
DOI
10.1056/nejmra2216474
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
- (2023) Carolin Steinack et al. Journal of Cystic Fibrosis
- Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on liver tests at a large single adult cystic fibrosis centre
- (2023) Daniel H Tewkesbury et al. Journal of Cystic Fibrosis
- Effects of elexacaftor/tezacaftor/ivacaftor therapy in children with cystic fibrosis – a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRI
- (2023) Carmen Streibel et al. Journal of Cystic Fibrosis
- Role of inhaled antibiotics in the era of highly effective CFTR modulators
- (2023) J. Stuart Elborn et al. European Respiratory Review
- Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2 Through 5 Years with Cystic Fibrosis and at Least One F508del Allele
- (2023) Jennifer L. Goralski et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic Fibrosis
- (2023) Jennifer L. Taylor-Cousar et al. CLINICAL THERAPEUTICS
- Cost-effectiveness analysis of genetic tools to predict treatment response in patients with cystic fibrosis
- (2023) Yeva Sahakyan et al. Journal of Cystic Fibrosis
- Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study
- (2023) S.M. Rowe et al. Journal of Cystic Fibrosis
- Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
- (2023) Linus Piehler et al. Frontiers in Pharmacology
- Assays of CFTR Function In Vitro, Ex Vivo and In Vivo
- (2022) Anabela S. Ramalho et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
- (2022) Clémence Martin et al. Journal of Cystic Fibrosis
- Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles
- (2022) Simon Y. Graeber et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry
- (2022) Sylvia Szentpetery et al. Journal of Cystic Fibrosis
- A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus
- (2022) Sylvia Szentpetery et al. Journal of Cystic Fibrosis
- Caution advised in the use of CFTR modulator treatment for individuals harboring specific CFTR variants
- (2022) Karen S. Raraigh et al. Journal of Cystic Fibrosis
- Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients
- (2022) Kathleen J. Ramos et al. Journal of Cystic Fibrosis
- The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial
- (2022) Harm A W M Tiddens et al. Lancet Respiratory Medicine
- Association of Body Mass Index With Clinical Outcomes in Patients With Cystic Fibrosis
- (2022) Rita Nagy et al. JAMA Network Open
- Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3B, Randomized, Placebo-Controlled Study
- (2022) Marcus A Mall et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Current state of CFTR modulators for treatment of Cystic Fibrosis
- (2022) Katherine A. Despotes et al. CURRENT OPINION IN PHARMACOLOGY
- Evaluating the state of the science for adeno-associated virus integration: An integrated perspective
- (2022) Denise E. Sabatino et al. MOLECULAR THERAPY
- One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies
- (2022) Marjolein M. Ensinck et al. Cells
- Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review
- (2022) Sara Manti et al. European Respiratory Review
- Progress in Respiratory Gene Therapy
- (2022) Gerry McLachlan et al. HUMAN GENE THERAPY
- Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand
- (2022) Adèle Coriati et al. THORAX
- Treatment Preference Among People With Cystic Fibrosis
- (2022) Rory A. Cameron et al. CHEST
- The Changing Epidemiology of Cystic Fibrosis
- (2022) Pierre-Régis Burgel et al. CHEST
- Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis
- (2022) Christopher Vélez et al. CLINICS IN CHEST MEDICINE
- Contemporary cystic fibrosis incidence rates in Canada and the United States
- (2022) Anne L. Stephenson et al. Journal of Cystic Fibrosis
- Variation in cystic fibrosis newborn screening algorithms in the United States
- (2022) Maryann R. Rehani et al. PEDIATRIC PULMONOLOGY
- Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care
- (2022) Siobhain Mulrennan et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
- (2022) Nicole Mayer-Hamblett et al. Lancet Respiratory Medicine
- Cystic Fibrosis Patients of Minority Race and Ethnicity Less Likely Eligible for CFTR Modulators Based on CFTR Genotype
- (2021) Meghan E. McGarry et al. PEDIATRIC PULMONOLOGY
- Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis
- (2021) Sanja Stanojevic et al. EUROPEAN RESPIRATORY JOURNAL
- Survival and lung transplant outcomes for individuals with advanced cystic fibrosis lung disease in the United States and Canada: an analysis of national registries
- (2021) Kathleen J. Ramos et al. CHEST
- Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
- (2021) Kiera H. Harwood et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation
- (2021) Yifat S. Oren et al. Journal of Cystic Fibrosis
- Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes
- (2021) Peter J. Barry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Magnetic resonance imaging of cystic fibrosis: Multi-organ imaging in the age of CFTR modulator therapies
- (2021) Kimberly McBennett et al. Journal of Cystic Fibrosis
- Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial
- (2021) Sivagurunathan Sutharsan et al. Lancet Respiratory Medicine
- Lung Transplantation for Cystic Fibrosis
- (2020) Jonathan C Yeung et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment
- (2020) Crésio Alves et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review
- (2020) Renée V. E. Dagenais et al. Journal of Clinical Medicine
- In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis
- (2019) Xingshen Sun et al. Science Translational Medicine
- Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
- (2019) Nataliya Volkova et al. Journal of Cystic Fibrosis
- Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial
- (2019) Felix Ratjen et al. Lancet Respiratory Medicine
- The future of cystic fibrosis care: a global perspective
- (2019) Scott C Bell et al. Lancet Respiratory Medicine
- Long-term effect of CFTR modulator therapy on airway nitric oxide
- (2019) Hartmut Grasemann et al. EUROPEAN RESPIRATORY JOURNAL
- Cystic fibrosis bone disease treatment: Current knowledge and future directions
- (2019) Melissa S. Putman et al. Journal of Cystic Fibrosis
- Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
- (2019) Peter G. Middleton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in Lung Clearance Index in Preschool Cystic Fibrosis Patients Treated with Ivacaftor
- (2018) Felix Ratjen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis
- (2018) Samuel T. Montgomery et al. Journal of Cystic Fibrosis
- VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
- (2018) Dominic Keating et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic sequencing in cystic fibrosis newborn screening: what works best, two-tier predefined CFTR mutation panels or second-tier CFTR panel followed by third-tier sequencing?
- (2017) Robert J Currier et al. GENETICS IN MEDICINE
- Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
- (2017) Philip M. Farrell et al. JOURNAL OF PEDIATRICS
- CFTR Modulator Therapy for Cystic Fibrosis
- (2017) Hartmut Grasemann NEW ENGLAND JOURNAL OF MEDICINE
- Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
- (2017) Steven M. Rowe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
- (2017) Jennifer L. Taylor-Cousar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Electrolyte transport properties in distal small airways from cystic fibrosis pigs with implications for host defense
- (2016) Xiaopeng Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Role of CFTR in epithelial physiology
- (2016) Vinciane Saint-Criq et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Body composition and lung function in cystic fibrosis and their association with adiposity and normal-weight obesity
- (2016) Jessica A. Alvarez et al. NUTRITION
- Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening
- (2015) A. Munck et al. Journal of Cystic Fibrosis
- Origins of Cystic Fibrosis Lung Disease
- (2015) David A. Stoltz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
- (2015) Alexandra L Quittner et al. THORAX
- Cystic fibrosis
- (2015) Felix Ratjen et al. Nature Reviews Disease Primers
- Aquagenic Wrinkling of the Palms in a Patient with Cystic Fibrosis
- (2013) Hartmut Grasemann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early lung disease in cystic fibrosis
- (2013) Hartmut Grasemann et al. Lancet Respiratory Medicine
- Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung
- (2012) Alejandro A. Pezzulo et al. NATURE
- Recommendations for the classification of diseases as CFTR-related disorders
- (2011) C. Bombieri et al. Journal of Cystic Fibrosis
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type of CFTR Mutation Determines Risk of Pancreatitis in Patients With Cystic Fibrosis
- (2010) Chee Y. Ooi et al. GASTROENTEROLOGY
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cystic Fibrosis Pulmonary Guidelines
- (2009) Patrick A. Flume et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis
- (2009) Reshma Amin et al. CHEST
- Pulmonary Complications of Cystic Fibrosis
- (2009) Patrick A Flume Respiratory Care
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started